US Stock MarketDetailed Quotes
HCA HCA Healthcare
- 350.530
- -7.460-2.08%
Close Nov 12 16:00 ET
- 350.010
- -0.520-0.15%
Pre 06:04 ET
88.79BMarket Cap15.74P/E (TTM)
358.150High350.320Low1.42MVolume357.710Open357.990Pre Close498.56MTurnover0.79%Turnover Ratio18.48P/E (Static)253.30MShares417.14052wk High-40.69P/B63.27BFloat Cap243.08252wk Low2.58Dividend TTM180.49MShs Float417.140Historical High0.74%Div YieldTTM2.19%Amplitude12.784Historical Low352.049Avg Price1Lot Size
HCA Healthcare Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 41.79%3.52B | -20.36%1.97B | 36.94%2.47B | 10.67%9.43B | 5.82%2.67B | -17.91%2.48B | 51.84%2.48B | 34.05%1.8B | -4.88%8.52B | 3.44%2.53B |
| Net income from continuing operations | 16.24%1.48B | 19.48%1.69B | 16.79%1.8B | -10.87%6.09B | -29.67%1.86B | -5.13%1.28B | 2.39%1.41B | 5.32%1.54B | -11.49%6.83B | 31.97%2.65B |
| Operating gains losses | 300.00%4M | -1,100.00%-12M | -1,440.00%-201M | 100.41%5M | 99.47%-7M | -166.67%-2M | -100.91%-1M | 250.00%15M | 23.94%-1.22B | -135.52%-1.33B |
| Depreciation and amortization | 9.49%842M | 7.34%819M | 5.16%795M | 3.64%3.08B | 5.20%789M | 2.67%769M | 3.39%763M | 3.28%756M | 4.07%2.97B | 3.02%750M |
| Deferred tax | -208.62%-63M | -21.41%-448M | 19.35%444M | -59.89%229M | -59.22%168M | 52.63%58M | -64.00%-369M | 7.51%372M | 915.71%571M | 261.57%412M |
| Other non cash items | 21.05%46M | 31.94%95M | -12.20%72M | 23.08%224M | -11.11%32M | -24.00%38M | 41.18%72M | 82.22%82M | 44.44%182M | 100.00%36M |
| Change In working capital | 319.33%1.13B | -152.03%-282M | 49.14%-530M | 60.33%-457M | -205.41%-226M | -64.09%269M | 206.69%542M | 21.00%-1.04B | -129.03%-1.15B | -118.00%-74M |
| -Change in receivables | 171.73%340M | -386.76%-195M | -137.82%-90M | -17.31%-935M | -147.42%-767M | -890.00%-474M | 156.67%68M | 155.74%238M | 17.15%-797M | -188.57%-310M |
| -Change in inventory | 833.33%252M | -66.67%-145M | 135.98%77M | -113.56%-126M | 232.14%148M | -94.76%27M | 74.49%-87M | -76.86%-214M | 89.07%-59M | 45.89%-112M |
| -Change in payables and accrued expense | -25.14%536M | -89.66%58M | 51.50%-517M | 304.05%604M | 12.93%393M | 311.49%716M | 1,293.62%561M | -38.26%-1.07B | -129.63%-296M | 29.85%348M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 41.79%3.52B | -20.36%1.97B | 36.94%2.47B | 10.67%9.43B | 5.82%2.67B | -17.91%2.48B | 51.84%2.48B | 34.05%1.8B | -4.88%8.52B | 3.44%2.53B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -3.05%-1.35B | -5.97%-1.33B | 21.55%-903M | -56.89%-5.32B | -101.39%-1.6B | -140.29%-1.31B | -4.32%-1.26B | -36.21%-1.15B | -28.23%-3.39B | 53.73%-793M |
| Net PPE purchase and sale | -3.84%-1.19B | -3.22%-1.28B | 6.60%-1.12B | -7.94%-4.74B | 12.40%-1.16B | -1.41%-1.15B | -14.91%-1.24B | -39.02%-1.2B | -22.87%-4.4B | -10.99%-1.32B |
| Net business purchase and sale | 36.99%-92M | -1,600.00%-34M | 328.00%214M | -143.63%-442M | -164.06%-344M | -125.52%-146M | 98.15%-2M | 316.67%50M | -3.98%1.01B | 222.88%537M |
| Net investment purchase and sale | -407.14%-71M | -433.33%-16M | 115.38%2M | -900.00%-112M | -2,150.00%-82M | -216.67%-14M | 75.00%-3M | -230.00%-13M | 111.97%14M | 105.06%4M |
| Net other investing changes | ---- | 90.91%-1M | -111.11%-1M | 9.52%-19M | -9.09%-12M | -600.00%-5M | -120.00%-11M | 250.00%9M | -425.00%-21M | -83.33%-11M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -3.05%-1.35B | -5.97%-1.33B | 21.55%-903M | -56.89%-5.32B | -101.39%-1.6B | -140.29%-1.31B | -4.32%-1.26B | -36.21%-1.15B | -28.23%-3.39B | 53.73%-793M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 90.28%-110M | 8.76%-1.09B | -67.72%-1.22B | 27.62%-4.09B | 43.47%-1.04B | 51.14%-1.13B | 37.80%-1.2B | -270.59%-725M | 15.01%-5.66B | -500.65%-1.84B |
| Net issuance payments of debt | 515.04%2.09B | 708.75%647M | -22.17%537M | -60.60%1.3B | -40.95%186M | 127.47%339M | -92.63%80M | -77.88%690M | 0.98%3.29B | -85.71%315M |
| Net common stock issuance | -57.46%-1.8B | -49.40%-1.37B | -39.48%-1.18B | 45.56%-3.81B | 40.09%-910M | -63.32%-1.14B | 65.88%-915M | 59.73%-846M | 14.79%-7B | 26.69%-1.52B |
| Cash dividends paid | -4.32%-169M | -4.27%-171M | -5.71%-185M | -1.23%-661M | -2.56%-160M | -1.25%-162M | -2.50%-164M | 1.13%-175M | -4.65%-653M | -5.41%-156M |
| Net other financing activities | -36.69%-231M | -1.51%-202M | 1.52%-388M | 28.91%-917M | 67.57%-155M | 24.89%-169M | -17.06%-199M | 5.52%-394M | -20.45%-1.29B | -64.26%-478M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 90.28%-110M | 8.76%-1.09B | -67.72%-1.22B | 27.62%-4.09B | 43.47%-1.04B | 51.14%-1.13B | 37.80%-1.2B | -270.59%-725M | 15.01%-5.66B | -500.65%-1.84B |
| Net cash flow | ||||||||||
| Beginning cash position | -3.60%831M | 52.49%1.28B | 2.97%935M | -37.42%908M | -10.81%891M | 0.47%862M | -64.49%842M | -37.42%908M | -19.07%1.45B | -2.73%999M |
| Current changes in cash | 5,765.71%2.05B | -2,370.00%-454M | 579.45%350M | 103.82%20M | 136.54%38M | -77.71%35M | 101.33%20M | -107.89%-73M | -54.28%-523M | -124.59%-104M |
| Effect of exchange rate changes | 166.67%4M | --1M | -114.29%-1M | 135.00%7M | -53.85%6M | 62.50%-6M | --0 | 240.00%7M | -566.67%-20M | 1,200.00%13M |
| End cash Position | 224.13%2.89B | -3.60%831M | 52.49%1.28B | 2.97%935M | 2.97%935M | -10.81%891M | 0.47%862M | -64.49%842M | -37.42%908M | -37.42%908M |
| Free cash flow | 74.47%2.32B | -44.08%690M | 122.94%1.35B | 13.57%4.69B | 25.83%1.52B | -29.49%1.33B | 124.36%1.23B | 25.21%606M | -23.32%4.13B | -3.76%1.2B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data